What's breaking now, across thousands of outlets.
The B.C. Human Rights Tribunal has ruled a B.C. doctor's refusal to treat a transgender teen with a prescribed hormone blocker as discriminatory
We haven't written up this one. Vancouver Sun has the full story — the link below goes straight to it.
Projected by some analysts as a future blockbuster, Isembyld is the first “muscle-targeted” treatment for the disease and, in clinical testing, helped improve motor function in people on standard…
There is a lot going on in the GLP-1 space, a market that landed $79 billion last year, and could shift significantly in the coming years.
John Harbaugh has a weird way of trying to prove a point.
Karachi: The government has extended the deadline for Umrah pilgrims travelling without vaccination. Pilgrims can now travel to Saudi Arabia without vaccination until September 25.
AstraZeneca disclosed that a breast cancer pill failed in a pivotal trial testing it as a first-line therapy in advanced tumors
Two people can take the same dose of the same medicine and have very different results. One may improve, while the other gets little benefit or develops serious side effects.
